Sierra Oncology Inc (SRRA) KOL Panel Highlights Momelotinib’s Efficacy - H.C. Wainwright
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| (NASDAQ: SRRA) | Delayed: 54.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.99 | 52 Week High | $ | |||
| Open | $16.72 | 52 Week Low | $ | |||
| Day High | $54.99 | P/E | N/A | |||
| Day Low | $54.99 | EPS | $ | |||
| Volume | 276,343 | |||||
